The Japanese pharmaceutical industry, a vital component of global innovation, faces a talent gap that resonates across multinational corporations. While Japan possesses a wealth of highly skilled professionals, a notable communication disparity impedes recruitment and career advancement, particularly in global…
HOME > LATEST
LATEST
-
REGULATORY Chugai’s DMD Gene Therapy Now in Line for Conditional Approval
April 21, 2025
-
REGULATORY Lower House Passes Bill to Amend PMD Act
April 21, 2025
-
REGULATORY MOF Tells LDP Members Govt Can Address Inflation with Current Budget Policy
April 21, 2025
-
BUSINESS Meiji/KM Biologics Change Target Strain of Investigational COVID Jab
April 21, 2025
-
BUSINESS Eye Drop for Myopia Control Enters PII Study in Japan: Rohto
April 21, 2025
-
ACADEMIA iPSC-Derived Cells Effective in Parkinson’s, Approval Could Come in FY2025
April 21, 2025
-
BUSINESS UCB Japan Launches IV Form of Epilepsy Med Briviact
April 18, 2025
-
REGULATORY MHLW Panel to Discuss Approval of ASKA’s Contraceptive Pill and More on April 25
April 18, 2025
-
ORGANIZATION PhRMA HTA Taskforce Warns CEA Expansion Will Accelerate Drug Loss in Japan
April 18, 2025
-
ORGANIZATION JPMA Sets Up Response Team to Collect Info on US Tariff Measures
April 18, 2025
-
BUSINESS Investments Follow Where Innovation Is Valued, Says Novartis Japan Chief
April 18, 2025
-
BUSINESS Gilead Shelves Sunlenca’s PrEP Program in Japan as Coverage Issue Weighs
April 17, 2025
-
BUSINESS Gilead Japan Revving Up Oncology Drive with Trodelvy, CAR-T as Legs of Growth
April 17, 2025
-
REGULATORY Lower House Health Committee OKs Bill to Amend PMD Act, Adopts Supplementary Resolution
April 17, 2025
-
BUSINESS Amgen Rolls Out Imdelltra for SCLC in Japan
April 17, 2025
-
REGULATORY MHLW Provides Draft Policymaking Document for Off-Year Revision after Opposition’s Call
April 17, 2025
-
ORGANIZATION Medical Advocacy Group Condemns Plan to Remove Coverage for OTC-Like Drugs
April 17, 2025
-
REGULATORY MHLW Looking into Impact of US Tariffs, Seeks Drug Makers’ Support
April 17, 2025
-
BUSINESS Eisai’s Alzheimer’s Drug Leqembi Now Approved in Europe
April 16, 2025
-
REGULATORY MHLW to Revise Patent Linkage Scheme in FY2025, Create Expert Committee
April 16, 2025
ページ
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…